News & Analysis as of

IP License › Third-Party

Bricker Graydon LLP

What You Need to Know about Business Use of Third-Party Photos

Bricker Graydon LLP on

In Part 1 of this two-part series, we introduced you to the various licensing models and special terminology unique to the photo/image licensing business. But knowing the terms and terminology is only half of the battle....more

Bricker Graydon LLP

What You Need to Know about Business Use of Third-Party Photos - Part 1

Bricker Graydon LLP on

You know it, instinctively if not empirically – there are many good reasons to use photos in your ads and print pieces and on your web pages – photos capture attention better than bold headlines and they add visual interest....more

Goodwin

European Commission’s First-Ever Abuse of Dominance Probe for Shelving of a Novel Pipeline Therapy

Goodwin on

The European Commission (EC) has launched a formal investigation under its abuse of dominance rules into US life sciences company Zoetis in the area of novel veterinary medicines. The EC alleges that the discontinuation of a...more

McDermott Will & Schulte

Back to the Future: Prior Third-Party Settlement Doesn’t Impact Future Trademark Licensees

McDermott Will & Schulte on

The US Court of Appeals for the Eleventh Circuit ruled that under certain circumstances a trademark licensee can bring a claim against a third party for unfair competition under the Lanham Act even if the licensing agreement...more

McDermott Will & Schulte

Third-Party Licensing Information May Be Exception to General Right of Public Access to Court Records

McDermott Will & Schulte on

In a second appeal relating to sealing third-party licensing information, the US Court of Appeals for the Federal Circuit vacated and remanded a district court’s order denying a motion to seal because the district court...more

Schwabe, Williamson & Wyatt PC

Latest Federal Court - February 2022 #2

Schwabe, Williamson & Wyatt PC on

Adapt Pharma Operations Limited v. Teva Pharmaceuticals USA, Inc., Appeal No. 2020-2106 (Fed. Cir. Feb. 10, 2022) - In our Case of the Week, the Court of Appeals for the Federal Circuit, in both the majority opinion and...more

Smart & Biggar

Countdown to July 1, 2020: Getting Ready for the New Patented Medicines Pricing Regime

Smart & Biggar on

On August 21st, the long-awaited amendments to the Patented Medicines Regulations were published in Part II of the Canada Gazette. We have prepared an unofficial consolidated version of the Regulations incorporating the...more

PilieroMazza PLLC

“March-in” Rights – The (Paper) Damoclean Sword of Federal Procurement Patent Law

PilieroMazza PLLC on

Given the recent PilieroMazza webinar on Data Rights in federal contracting, we have had a number of clients raise concerns or questions about the government’s “march-in” rights under the Bayh-Dole Act, which controls certain...more

8 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide